Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Cerus Corporation (CERS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cerus's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.150 +0.020    +0.48%
02/12 - Closed. Currency in USD ( Disclaimer )
After Hours
4.150
-0.000
-0.000%
16:15:39 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 975,387
  • Bid/Ask: 3.800 / 4.250
  • Day's Range: 3.890 - 4.160
Cerus 4.150 +0.020 +0.48%

CERS News

 
This page features the latest news about the Cerus stock.
Cerus Earnings Beat, Revenue Misses In Q3
Cerus Earnings Beat, Revenue Misses In Q3 By Investing.com - Nov 03, 2022

Investing.com - Cerus (NASDAQ:CERS) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Cerus announced earnings per share of...

Cerus Tops Q3 EPS by 2c; Offers FY22 Revenue Guidance
Cerus Tops Q3 EPS by 2c; Offers FY22 Revenue Guidance By Investing.com - Nov 03, 2022

Cerus (CERS) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $46.34 million versus the consensus estimate of $47.38...

Cerus Tops Q1 EPS by 2c
Cerus Tops Q1 EPS by 2c By Investing.com - May 05, 2022

Cerus (NASDAQ:CERS) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $43 million versus the consensus estimate of $38.98...

Notable earnings after Thursday’s close
Notable earnings after Thursday’s close By Seeking Alpha - Oct 31, 2018

AAPL, ACIA, ACLS, AIRG, AIV, ALEX, AMH, ANET, AOSL, APPN, ARCB, ATGE, ATHN, ATR, ATRC, ATSG, BCOV, BFAM, BIO, BL, BLDR, BNFT, BRKR, BVX, CARB, CATM, CBPO, CBS, CC, CCRN, CECO, CERS, CHEF, CNMD, CNXN,...

After Hours Gainers / Losers (1/23/2018)
After Hours Gainers / Losers (1/23/2018) By Seeking Alpha - Jan 23, 2018

Top gainers: CERS +20.1%. ARAY +7.7%. CASC +2.5%. OBSV +2.0%. TVIX +2.0%.Top losers: PBYI -27.9%. SIGM -11.4%. RCKT -7.8%. TK -7.3%. TXN -6.7%. Now read: Teekay Corporation - Market Position And...

Premarket analyst action - healthcare
Premarket analyst action - healthcare By Seeking Alpha - Jan 05, 2018

AmerisourceBergen (NYSE:ABC) initiated with Outperform rating and $105 (12% upside) price target by Evercore ISI.Arbutus Biopharma (NASDAQ:ABUS) initiated with Buy rating and $10 (82% upside) price...

Cerus on go to initiate Phase 3 ReCePI study
Cerus on go to initiate Phase 3 ReCePI study By Seeking Alpha - Dec 08, 2017

Cerus Corporation (NASDAQ:CERS) announces that the FDA has approved its IDE to initiate a Phase 3 clinical trial, ReCePI, assessing INTERCEPT Red Blood Cells (RBCs) in patients undergoing...

Healthcare - Top 5 Gainers / Losers as of 11:00 am
Healthcare - Top 5 Gainers / Losers as of 11:00 am By Seeking Alpha - Nov 03, 2017

Gainers: CERS +18%. PODD +17%. BIO +16%. ABUS +16%. MOH +15%.Losers: GNMK -36%. NSTG -21%. BVX -20%. PACB -17%. VYGR -10%.Now read: AVEO Pharmaceuticals: Buy The DipOriginal article

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CERS Comments

Write your thoughts about Cerus Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Neil Garvin
Neil Garvin Aug 26, 2020 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why the plunge yesterday on supposed good news? No mention of that anywhere.
Valeriy Katsenko
Valeriy Katsenko Aug 24, 2020 10:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.statnews.com/2020/08/23/fda-under-pressure-from-trump-expected-to-authorize-blood-plasma-as-covid-19-treatment/
Daniel Humphrey
Daniel Humphrey Feb 17, 2017 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's triggering the sudden rise?
chad gray
chad gray Feb 17, 2017 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Think its the coronavirus scare, maybe testing
Travis Thompson
Travis Thompson Feb 17, 2017 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Upcoming earnings on Feb 20
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email